C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...
During pregnancy, the maternal immune system must engage in a fine balancing act: maintaining tolerance to the fetal ...
Awarded to Dr Hayley Lavender (pictured right) and Dr Paraskevi (Pari) Kritsiligkou, the awards support biomedical ...
Two researchers from the University of Liverpool's Faculty of Health and Life Sciences have been awarded prestigious ...
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
Zurich, Zurich - April 10, 2026 - PRESSADVANTAGE - IntroDrink, the Swiss premium natural health retailer, has expanded ...
Microbial infections, caused by bacteria, viruses, and parasites, pose a significant challenge to global health, affecting millions annually. Despite advancements in medical science, understanding the ...
EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in CanadaApproval supported ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that data from the Phase 3 study of vilobelimab ...
Northwestern Medicine investigators have uncovered a missing link behind the harmful effects of autoantibodies linked to blood clots, pregnancy complications and other inflammatory conditions, ...
A common eye-health nutrient, zeaxanthin, may also help the body fight cancer more effectively. Scientists discovered it strengthens T cells and enhances the impact of immunotherapy treatments. Found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results